In this blog post we will discuss the basics of cloud computing, benefits and considerations of cloud vs. traditional deployments, and how our Professional Services team can help you optimize your cloud deployment.
Taking HALO® to the Cloud with Indica Labs Cloud Services Read More »
Melanoma, a highly aggressive type of skin cancer originating from pigment-producing cells called melanocytes, can be a source of diagnostic confusion for pathologists. While primary
High-grade serous ovarian cancer (HGSC) is known to have a high degree of both genetic and immunologic heterogeneity, can be resistant to chemotherapy, and commonly
SARS-CoV-2 vaccines based on the ancestral Wuhan-Hu-1 Spike (S) protein have been shown to be effective in preventing severe COVID-19, hospitalization, and death. The evolution
HALO AP® 2.2 is now available! Submit the form below to request your upgrade. How it works: Following submission of an upgrade request form, a
HALO AP 2.2 Upgrade form Read More »
Indica Labs’ Pharma Services is a growing team of experienced image analysts and imaging scientists with backgrounds in digital pathology, immuno-oncology, cancer biology, neuroscience, bioinformatics, and data science.
Finding the Right Expertise and Tools with Indica Labs’ Pharma Services Read More »
Albuquerque, NM, – 26 June 2023 – Indica Labs, a leading provider of computational pathology software, is delighted to announce that they have been awarded a Top Workplaces™ honor by The Albuquerque Journal for the fourth year in a row.
An Interview with Ines Nearchou, Senior Imaging Scientist, Pharma Services – Indica Labs
An Interview with Ines Nearchou, Senior Imaging Scientist, Pharma Services Read More »
SARS-CoV-2, the causative agent of COVID-19, has been the focus of intense research since its detection in late 2019. It is known that viral infection
Schwannomas are sporadic, usually benign tumors that develop predominately on spinal nerve roots and cranial nerves. Inactivation of NF2 in Schwann cells (SC) is the
Cellular mechanisms of heterogeneity in NF2-mutant schwannoma Read More »
